There were 348 press releases posted in the last 24 hours and 185,974 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Medigene enters Phase I clinical development with its TCR-T immunotherapy MDG1021 in hematological cancers

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image